Nylim CND US MD CP Eq ETF-UiIQSMETF

13F holders, Q4 2025 (December 31)
6holders −1
0new positions
1sold out
$34.62avg. 13F price*

At the end of Q4 2025, 6 institutions reported holding Nylim CND US MD CP Eq ETF-Ui (IQSM) in their 13F filings, down 1 from Q3 2025. 0 opened new positions and 1 sold out. The largest holders were New York Life Investment Management LLC ($200.0M), Seeds Investor LLC ($3.4M) and Cetera Investment Advisers ($2.7M).

Company
Nylim CND US MD CP Eq ETF-Ui
Filed as
NEW YORK LIFE INVESTMENTS ET (Q4 2025)
CUSIP
45409B248
Latest filing quarter
Q2 2026

History

Number of 13F holders

02468 Q1 2024: 3Q1 2024Q2 2024: 2Q2 2024Q3 2024: 3Q3 2024Q4 2024: 3Q4 2024Q1 2025: 3Q1 2025Q2 2025: 3Q2 2025Q3 2025: 7Q3 2025Q4 2025: 6Q4 2025Q1 2026: 6Q1 2026Q2 2026: 7Q2 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions0$0
Exits1$441

All 13F filers, Q3 2025 → Q4 2025: 87 shares bought and 407,592 shares sold, net −407,505 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 6 holders

New York Life Investment Management LLC 1.72% Reduce -6.3% 5,775,886 $200.0M
Seeds Investor LLC 0.66% Reduce -14.4% 99,268 $3.4M
Cetera Investment Advisers 0.00% Reduce -3.5% 78,423 $2.7M
Susquehanna International Group, LLP 0.00% Reduce -6.5% 9,571 $331K
Rossby Financial, LCC 0.03% Reduce -2.2% 3,186 $110K
Morgan Stanley 0.00% Add +669.2% 100 $3K

"% of holder's portfolio" is IQSM's weight in each manager's 13F, not the share of Nylim CND US MD CP Eq ETF-Ui the manager owns.